231 related articles for article (PubMed ID: 4419263)
1. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
Jacobs C; Heinen G; Schmal E
Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
[No Abstract] [Full Text] [Related]
2. [Amenorrhea, anovulation and oligomenorrhea due to use of oral contraceptives].
James M; Rozenbaum H
Concours Med; 1974 Mar; 96(10):1559-60, 1563-4, 1567-8. PubMed ID: 4619979
[No Abstract] [Full Text] [Related]
3. A new progestogen-estrogen combination for gynecologic therapy and contraception.
Linthorst G
Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
[No Abstract] [Full Text] [Related]
4. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
Willmes HG
Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
[No Abstract] [Full Text] [Related]
5. [Mycoses and oral contraception of the biphasic type].
Eimer H
Brux Med; 1974 Sep; 54(9):511-4. PubMed ID: 4410194
[TBL] [Abstract][Full Text] [Related]
6. A new oral contraceptive based on the normophasic method.
Bolle J; Poulain A
Arzneimittelforschung; 1976; 26(3):441-3. PubMed ID: 989342
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
Kaltreider DF
Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
[No Abstract] [Full Text] [Related]
8. [Restovar, a new combined oral contraceptive with a low estrogen content].
Fondu F; Lowijck J
Brux Med; 1974 Aug; 54(8):453-8. PubMed ID: 4425958
[No Abstract] [Full Text] [Related]
9. [Porphyria cutanea tarda after prolonged taking of oral contraceptives].
Degos R; Touraine R; Kalis B; Delort J; Bonvalet D
Ann Dermatol Syphiligr (Paris); 1969; 96(1):5-14. PubMed ID: 5367491
[TBL] [Abstract][Full Text] [Related]
10. Sterility following oral contraceptives.
Dunn HP
N Z Med J; 1967 Apr; 66(416):261. PubMed ID: 5229764
[No Abstract] [Full Text] [Related]
11. [Phlebitis and chloasma in patient taking oral contraceptives].
Merklen FP; Cottenot F; Potier JC
Bull Soc Fr Dermatol Syphiligr; 1967; 74(6):801-3. PubMed ID: 5590531
[No Abstract] [Full Text] [Related]
12. Oestrogen content of oral contraceptives and thromboembolism.
McQueen EG
N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982
[No Abstract] [Full Text] [Related]
13. [Letter: Relative estrogen deficiency caused by contraceptives].
Bailer P
Dtsch Med Wochenschr; 1973 Nov; 98(45):2162. PubMed ID: 4757978
[TBL] [Abstract][Full Text] [Related]
14. [Lyndiol, a new low-dose oral contraceptive].
Altkemper R
Med Monatsschr; 1973 Jul; 27(7):326-8. PubMed ID: 4727513
[No Abstract] [Full Text] [Related]
15. [Clinical experiences with gestagen therapy of various gynecologic diseases].
György G; László J
Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686
[No Abstract] [Full Text] [Related]
16. [Colposcopic findings in women treated with oral estrogen-progestagens].
Gacci G
Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1575-80. PubMed ID: 5744200
[No Abstract] [Full Text] [Related]
17. [Changes in the heparinocyte count during intake of hormonal contraceptives].
Frick G; Kühne D
Zentralbl Gynakol; 1973 Oct; 95(41):1441-50. PubMed ID: 4129504
[No Abstract] [Full Text] [Related]
18. The oversuppression syndrome.
Horowitz BJ; Solomkin M; Edelstein SW
Obstet Gynecol; 1968 Mar; 31(3):387-9. PubMed ID: 5639193
[No Abstract] [Full Text] [Related]
19. [Medical indications for the prescription of ovulation inhibitors in gynecologic practice].
Willmes HG
Med Welt; 1969 Mar; 10():526-31. PubMed ID: 4239080
[No Abstract] [Full Text] [Related]
20. [A new normophasic estro-progestational combination: fisioquens].
Cavrot E; Moulinasse R
Brux Med; 1974 Aug; 54(8):459-63. PubMed ID: 4425959
[No Abstract] [Full Text] [Related]
[Next] [New Search]
